Richard Buchholz - Apr 17, 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role: Chief Financial Officer
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Stock symbol: INSP
Transactions as of: Apr 17, 2024
Transactions value $: -$3,450,450
Form type: 4
Date filed: 4/18/2024, 04:44 PM
Previous filing: Feb 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSP	Common Stock	Sale	-$3.45M	-15K	-34.67%	$230.03	28.3K	Apr 17, 2024	Direct	F1, F2
transaction	INSP	Common Stock	Gift	$0	-500	-1.77%	$0.00	27.8K	Apr 17, 2024	Direct
transaction	INSP	Common Stock	Gift	$0	+125	+10.2%	$0.00	1.35K	Apr 17, 2024	By daughter
transaction	INSP	Common Stock	Gift	$0	+125	+10.2%	$0.00	1.35K	Apr 17, 2024	By son
transaction	INSP	Common Stock	Gift	$0	+125	+10.2%	$0.00	1.35K	Apr 17, 2024	By son
transaction	INSP	Common Stock	Gift	$0	+125	+10.2%	$0.00	1.35K	Apr 17, 2024	By son

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.